Class IITerminatedD-0622-2018
Drug recall · April 18, 2018
Molleave recall
Why: cGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
- Lots / codes
All product within expiry
- Quantity
- Unknown
- Company
- Elroselabs Inc., Sanford, FL
- Distribution
- Nationwide.
- Initiated
- March 28, 2018 · Voluntary: Firm initiated
- Classified
- April 6, 2018
- Reported
- April 18, 2018
- Ended
- December 15, 2020
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.